Skip to main content
. 2011 Dec 12;6(12):e28887. doi: 10.1371/journal.pone.0028887

Figure 3. The Aβ-mediated decrease in estradiol levels is prevented by AG18051.

Figure 3

(A) Scheme of pre- and co-incubation treatment. (B) Pre-treatment of cells with AG18051 for 24 hours prior to adding Aβ42 maintains estradiol levels compared to the vehicle control, (C) as does co-treatment. **, P<0.01.